Fair Value Measurements and Investments - Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) - Neo Medical [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of convertible loans beginning balance	$ 6,760	$ 7,140
Interest recognized in interest income, net	135	116
Foreign currency remeasurement recognized in other income (expense), net	(471)	61
Unrealized gain (loss) recognized in other comprehensive loss	1,671	(137)
Reversal of expected credit loss recognized in other income (expense), net	260
Fair value of convertible loans ending balance	8,355	7,180
Contractual value of Neo Medical Convertible Loans at January 1			$ 6,683	$ 6,084
Amortized cost basis of Neo Medical Convertible Loans at March 31	$ 6,683	$ 6,084